This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1976.
Company Filing History:
Years Active: 1976
Title: Phyllis Roberta Hedwall: Innovator in Antihypertensive Compositions
Introduction
Phyllis Roberta Hedwall is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive compositions. Her work has implications for the treatment of hypertension, showcasing her innovative spirit and dedication to improving health outcomes.
Latest Patents
Hedwall holds a patent for "Antihypertensive compositions - Pyridines of the formula I," which includes various chemical structures and compounds. This patent is particularly focused on compositions that serve as dopamine-β-hydroxylase inhibitors. The specific formula includes components where R1 can be a variety of functional groups, and R2 can be oxygen or sulfur, among other specifications. This innovation represents a significant advancement in the treatment of hypertension.
Career Highlights
Throughout her career, Phyllis Roberta Hedwall has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. Her work has not only contributed to the company's portfolio but has also advanced the field of antihypertensive medications. Hedwall's dedication to research and development has positioned her as a key figure in her area of expertise.
Collaborations
Hedwall has collaborated with esteemed colleagues such as Hans Kuhnis and Christian Egli. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their collective work.
Conclusion
Phyllis Roberta Hedwall's contributions to the field of antihypertensive compositions highlight her role as an influential inventor. Her patent and collaborations reflect her commitment to advancing medical science and improving patient care. Her work continues to inspire future innovations in the pharmaceutical industry.